Ohara Gains Rights to BTG's Glucarpidase in Japan - Genetic Engineering News PDF Print
Genetic Engineering News
Glucarpidase is an experimental treatment for the rapid and sustained reduction of toxic methotrexate (MTX) levels due to impaired renal function. Under terms of the agreement BTG will also supply glucarpidase to Ohara. Ohara will be responsible for

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.